An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditions

Early detection of atrial fibrillation (AF) enables initiation of anticoagulation and early rhythm control therapy to reduce stroke, cardiovascular death, and heart failure. In a cross-sectional, observational study, we aimed to identify a combination of circulating biomolecules reflecting different...

Descripción completa

Detalles Bibliográficos
Autores principales: Chua, Winnie, Cardoso, Victor R., Guasch, Eduard, Sinner, Moritz F., Al-Taie, Christoph, Brady, Paul, Casadei, Barbara, Crijns, Harry J. G. M., Dudink, Elton A. M. P., Hatem, Stéphane N., Kääb, Stefan, Kastner, Peter, Mont, Lluis, Nehaj, Frantisek, Purmah, Yanish, Reyat, Jasmeet S., Schotten, Ulrich, Sommerfeld, Laura C., Zeemering, Stef, Ziegler, André, Gkoutos, Georgios V., Kirchhof, Paulus, Fabritz, Larissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556075/
https://www.ncbi.nlm.nih.gov/pubmed/37798357
http://dx.doi.org/10.1038/s41598-023-42331-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556075/
https://www.ncbi.nlm.nih.gov/pubmed/37798357
http://dx.doi.org/10.1038/s41598-023-42331-7

Ejemplares similares